Retinopathy of Prematurity (ROP) in Newborns and Premature Infants: Advice for Libyan and Nigerian Families

The importance of eye examinations for preterm infants placed in incubators and on oxygen to prevent early retinal complications at Mashreq Center with Dr. Mahmoud Hassan.

Retinopathy of Prematurity (ROP) in Newborns and Premature Infants: A Glimmer of Hope for Families in Libya and Niger

Premature birth is a significant challenge for families worldwide, and these challenges become even more complex when it comes to the eye health of these infants. Retinopathy of Prematurity (ROP) is a serious medical condition that can lead to visual impairment or even permanent blindness if not detected and treated promptly. In this article, we shed light on this important condition, focusing on providing practical advice for families in Libya and Niger, two countries that may face particular challenges in accessing specialized care.

What is Retinopathy of Prematurity (ROP)?

Retinopathy of Prematurity is a disorder affecting the developing blood vessels in the retina of infants born prematurely. The retina consists of light-sensitive cells responsible for vision, and its blood vessels fully develop during the final months of pregnancy. In premature births, these blood vessels may not have completed their development, making them susceptible to abnormal growth. This abnormal growth can lead to the formation of scar tissue in the retina, which in turn can pull the retina away from its normal position, causing retinal detachment and permanent vision loss.

It is worth noting that the intensive use of oxygen in incubators, often necessary to save the lives of these infants, can be a contributing factor to the development of the condition, although its benefits often outweigh its risks. The primary goal is to balance the need for oxygen with the need for careful monitoring of the infant's eyes.

Who are the most susceptible infants?

The likelihood of developing Retinopathy of Prematurity increases with earlier birth and lower birth weight. Other risk factors include:

• Birth before 31 weeks of gestation.
• Birth weight less than 1500 grams.
• Need for prolonged oxygen therapy.
• Presence of other health problems in the infant such as infection, respiratory problems, or cerebral hemorrhage.
• Family history of Retinopathy of Prematurity.

The Importance of Early Screening for Infants in Libya and Niger

In regions such as Libya and Niger, families may face difficulties in accessing specialized medical centers and precise eye examinations. However, the importance of early screening for Retinopathy of Prematurity in newborns and premature infants cannot be overstated. Early detection is key to successful treatment and prevention of serious complications. Doctors and nurses in Neonatal Intensive Care Units (NICU) in these countries should be fully aware of this condition and ensure that at-risk infants are referred to pediatric ophthalmologists for timely and necessary examinations.

Retinal examinations should typically begin approximately 4 weeks after the estimated due date and be repeated regularly as per the doctor's recommendations. Examination using an Ophthalmoscope or Direct Ophthalmoscope can help detect any abnormal signs in the retinal blood vessels. In Retinopathy of Prematurity in Newborns and Premature Infants: Advice for Libyan and Nigerien Families, we emphasize the need for coordination between local doctors and specialized centers to ensure that these infants receive the care they need.

Available Treatment Options

Treatment depends on the stage and severity of the disease. In very early cases, the infant may not require treatment and only close monitoring is sufficient. However, if the condition progresses, treatment options may include:

• Cryotherapy: Abnormal peripheral parts of the retina are frozen to stop their growth and prevent new scar tissue formation.
• Laser Photocoagulation: Laser is used to burn abnormal blood vessels in the retina.
• Intravitreal Injections: Medications such as Bevacizumab or Ranibizumab are used to stop the growth of abnormal blood vessels. These medications, like Eylea, have proven effective in many cases.

At Al-Mashreq Eye Center, under the supervision of Dr. Mahmoud Hassan, each case is carefully evaluated to determine the most appropriate treatment plan. We understand the challenges families may face in accessing these advanced treatments, and we always strive to provide the best possible care.

Advice for Libyan and Nigerien Families

We understand that traveling to specialized medical centers can be difficult and costly. Therefore, we offer these practical tips:

• Early Awareness: Talk to pediatricians and obstetricians about the risks of Retinopathy of Prematurity in newborns and premature infants and the importance of early screening.
• Contact Health Centers: Inquire about the possibility of basic eye exams at local health centers, even if limited, to assess risks.
• Seek Support: Look for non-profit organizations or charities that may provide assistance with travel or treatment costs for children in need.
• Utilize Technology: If possible, take advantage of Telemedicine consultations with specialized ophthalmologists to discuss your children's conditions and receive initial guidance.
• Plan Ahead: If travel to Egypt for treatment is necessary, start planning early. Al-Mashreq Eye Center can assist with coordinating appointments and accommodation for international patients.

The Role of Dr. Mahmoud Hassan and Al-Mashreq Eye Center

As a key contributor to Al-Mashreq Eye Center, Dr. Mahmoud Hassan is committed to providing the highest standards of specialized care in retina and vitreous surgery, including the treatment of Retinopathy of Prematurity in newborns and premature infants. We understand the importance of access to these services, especially for patients from outside Egypt. Our team is always ready to provide support and advice, and assist you on your children's journey towards a better visual future.

Do not hesitate to contact us for a consultation or for more information about available retinal examinations and treatments. You can follow more important medical advice through my YouTube channel: .

For reservations and inquiries: 01002310813

Articles you might like to read

• Central Retinal Vein Occlusion (CRVO): Symptoms, Causes of Clot, and Latest Treatments
• Important Instructions After Vitrectomy and Recovery Tips

https://drmahmoud-hassaan.com/en/articles/rop-infants-screening-advice-libya-niger